Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
Getein Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is used for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider.
Getein FluA/ FluB/ SARS-CoV-2 Real-time RT-PCR Kit is used to quickly identify whether a patient is infected with influenza A, influenza B or SARS-CoV-2, thereby effectively controlling viral infection.
Subscribe to our weekly newsletter and receive exclusive offers on products you love!
X
